Pharmacovigilance is defined as the science and activities involved in the detection, evaluation, understanding, and prevention of adverse effects, adverse reactions, and events related to vaccinations or immunizations, as well as any other safety issues associated with the use of medications and vaccines.
A suspected adverse reaction refers to any undesirable clinical or laboratory manifestation that occurs after the administration of one or more medications.
At Loeffler Russek Group, we are committed to patient safety and strict compliance with current regulations. If you experience any suspected adverse reaction, we urge you to consult your doctor and report it immediately to our Pharmacovigilance Unit.
If you notice any unexpected changes or discomfort while using our medications, please contact our Pharmacovigilance Unit at 55 2626 9100, available from 8:00 AM to 5:45 PM on business days.
In accordance with legal requirements, any reported suspected adverse reaction will be submitted to the National Pharmacovigilance Center (CNFV), which operates under the Federal Commission for Protection Against Health Risks (COFEPRIS). This process helps contribute to the detection, evaluation, and prevention of adverse reactions and safety issues associated with medications.
Rest assured that all information you provide will be handled in compliance with the Federal Law for the Protection of Personal Data Held by Private Parties. For details, please refer to our Privacy Notice.
